Skip to main content
    C

    Cerus Corporation (CERS)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $1.86
    -0.12 (-6.30%)

    Market Cap: $400.88M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Cerus Corporation (CERS) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Cerus are Avita Medical (RCEL), Delcath Systems (DCTH) and Treace Medical Concepts (TMCI). By market cap, Cerus ranks 9th of the 13 companies on this page; Beta Bionics, Inc. Common Stock (BBNX) is the largest at $892.71M. The median P/E of the 5 companies with a P/E is 27.8x.

    Peer Comparison

    CERS's ROIC of -0.2% is above the peer median of -18.0%, and its revenue growth of 9.5% is above the median of 6.3%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Cerus (CERS)$400.88MN/A1.6x-3.2%-0.2%9.5%0.00%
    Avita Medical Ltd (RCEL)$491.10MN/A5.5x-42.6%-159.3%53.1%0.00%
    Delcath Systems Inc (DCTH)$714.89M124.2x6.5x6.0%N/A70.7%0.00%
    Treace Medical Concepts Inc (TMCI)$345.50MN/A1.4x-27.4%-32.8%-3.9%0.00%
    Senseonics Holdings, Inc. Common Stock (SENS)$579.58MN/A11.9x-204.2%-71.4%141.6%0.00%
    Beta Bionics, Inc. Common Stock (BBNX)$892.71MN/A5.6x-65.3%-18.0%30.3%0.00%
    QuidelOrtho Corp (QDEL)$736.90M11.9x0.3x-14.2%-2.9%-11.6%0.00%
    Pacific Biosciences of California (PACB)$611.98MN/A3.5x-81.3%-21.1%5.5%0.00%
    Brainsway Ltd (BWAY)$406.96M27.8x3.4x15.6%N/A35.4%0.00%
    Neuropace Inc (NPCE)$260.45MN/A2.9x-17.7%-16.7%-1.1%0.00%
    InfuSystems Holdings Inc (INFU)$294.89M29.6x2.0x6.5%12.1%3.0%0.00%
    Standard Biotools Inc (LAB)$279.27MN/A3.8x157.6%-9.9%-0.9%0.00%
    Tactile Systems Technology Inc (TCMD)$600.58M23.7x1.7x6.7%N/A7.1%0.00%
    Peer median$535.34M27.8x3.5x-15.9%-18.0%6.3%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Cerus, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Medical Devices.

    CompanyAboutPeers
    Avita Medical Ltd (RCEL)
    AVITA Medical Inc. is a commercial stage regenerative tissue company in the United States, Australia, and the United Kingdom.
    RCEL competitors
    Delcath Systems Inc (DCTH)
    Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe.
    DCTH competitors
    Treace Medical Concepts Inc (TMCI)
    Treace Medical Concepts, Inc., an orthopedic medical device company, is dedicated to the design, manufacture...
    TMCI competitors
    Senseonics Holdings, Inc. Common Stock (SENS)
    Senseonics Holdings, Inc., a medical technology company, develops and markets continuous glucose monitoring (CGM) systems for people with diabetes in the United...
    SENS competitors
    Beta Bionics, Inc. Common Stock (BBNX)
    Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development...
    BBNX competitors
    QuidelOrtho Corp (QDEL)
    Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for infectious disease, cardiology, thyroid, general and women's health...
    QDEL competitors
    Pacific Biosciences of California (PACB)
    Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to solve genetically complex problems.
    PACB competitors
    Brainsway Ltd (BWAY)
    Brainsway Ltd., a commercial-stage medical device company, focuses on the development and sale of non-invasive neuromodulation products in Israel...
    BWAY competitors
    Neuropace Inc (NPCE)
    NeuroPace, Inc. is a medical device company in the United States. The company is headquartered in Mountain View, California.
    NPCE competitors
    InfuSystems Holdings Inc (INFU)
    InfuSystem Holdings, Inc., provides infusion pumps and related products and services in the United States and Canada.
    INFU competitors
    Standard Biotools Inc (LAB)
    Standard Biotools Inc. (LAB) is a pioneering biotechnology company dedicated to enhancing genomic analysis and biological research through cutting-edge tools...
    LAB competitors
    Tactile Systems Technology Inc (TCMD)
    Tactile Systems Technology, Inc., a medical technology company, is dedicated to the development and supply of medical devices for chronic diseases in the United...
    TCMD competitors

    Frequently Asked Questions About CERS

    Who are Cerus' main competitors?

    The companies most similar to Cerus include Avita Medical (RCEL), Delcath Systems (DCTH), Treace Medical Concepts (TMCI), Senseonics Holdings, Inc. Common Stock (SENS) and Beta Bionics, Inc. Common Stock (BBNX), listed from the closest match.

    Who is Cerus' biggest competitor?

    Beta Bionics, Inc. Common Stock (BBNX) is the largest of the similar companies at $892.71M; Avita Medical (RCEL) is the closest match by business profile, size, sector and industry.

    How does CERS stock compare with its competitors?

    CERS' P/S is 1.6x against a peer median of 3.5x; its net margin is -3.2% against a peer median of -15.9%.

    Which of Cerus' competitors pays a higher dividend?

    Cerus pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Cerus bigger than its competitors?

    No. Cerus is 9th by market cap among the 13 companies on this page; the largest is Beta Bionics, Inc. Common Stock (BBNX) at $892.71M.